Back to Search
Start Over
Personalise treatment for rosacea by selecting from a range of options for individual features.
Personalise treatment for rosacea by selecting from a range of options for individual features.
- Source :
-
Drugs & Therapy Perspectives . Jun2024, Vol. 40 Issue 6, p221-225. 5p. - Publication Year :
- 2024
-
Abstract
- Rosacea is a chronic, inflammatory condition of facial skin. Treatment of rosacea should be based on its presenting features i.e. inflammatory lesions, erythema, phymas and/or telangiectasia. First-line treatment options for inflammatory lesions include metronidazole, azelaic acid, ivermectin and modified-release doxycycline, but topical formulations of minocycline foam and encapsulated benzoyl peroxide are also now available. Persistent erythema can be treated with topical α-adrenergic receptor agonists or light-based therapies. Approved pharmacological options for phymas and telangiectasia are limited; nonpharmacological procedures should be considered in some cases. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 11720360
- Volume :
- 40
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Drugs & Therapy Perspectives
- Publication Type :
- Academic Journal
- Accession number :
- 178778126
- Full Text :
- https://doi.org/10.1007/s40267-024-01081-w